A View from the Laboratory: Basic Science and Translational Research
Key St. Jude supporters and stakeholders were invited to participate in a conference call to hear how St. Jude is changing the way the world understands, treats and defeats childhood cancer.
Richard C. Shadyac Jr., President and CEO of ALSAC/St. Jude, was joined by Michael Dyer, Ph.D., director of the Division of Developmental Biology and co-leader of the Developmental Biology and Solid Tumor Program at St. Jude. Dr. Dyer shared updates about his research and what sets St. Jude apart from other hospitals.